Genetic alterations distinguish different types of ovarian tumors

被引:71
作者
Pieretti, M
Cavalieri, C
Conway, PS
Gallion, HH
Powell, DE
Turker, MS
机构
[1] UNIV KENTUCKY, DEPT LAB MED & PATHOL, LEXINGTON, KY 40536 USA
[2] UNIV KENTUCKY, DEPT OBSTET & GYNECOL, LEXINGTON, KY 40536 USA
关键词
D O I
10.1002/ijc.2910640614
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Seventy-four sporadic ovarian tumors were studied for loss of heterozygosity (LOH) and microsatellite instability (MI) with 20 polymorphic markers on chromosome 17 and at least I marker on every other chromosome. Additionally, activation of the K-ros oncogene was examined through mutation analysis of codon IZ. A majority of the tumors analyzed were low grade and/or of the mucinous histologic type. A negative correlation between LOH on chromosome 17 and K-ros activation was observed, with the former alteration present in the majority of high grade serous and endometrioid tumors and the latter most commonly found in the mucinous and low malignant potential (LMP) tumors. In 60% of cases where LOH on chromosome 17 was present, it was observed at all informative markers, indicating chromosome loss. In these cases, frequent events of LOH were observed on the other chromosomes. When confined events of LOH were observed on chromosome 17, fewer events of LOH were observed on the other chromosomes. In the absence of LOH on chromosome 17, LOH on other chromosomes was rare. K-ras activation was most commonly observed in tumors with no LOH events. Two endometrioid tumors and 2 mucinous tumors demonstrated MI. Our data support the involvement of different molecular pathways in the development of different types of ovarian tumors. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:434 / 440
页数:7
相关论文
共 21 条
[1]  
ECCLES DM, 1992, ONCOGENE, V7, P2069
[2]   VERY FREQUENT LOSS OF HETEROZYGOSITY THROUGHOUT CHROMOSOME-17 IN SPORADIC OVARIAN-CARCINOMA [J].
FOULKES, WD ;
BLACK, DM ;
STAMP, GWH ;
SOLOMON, E ;
TROWSDALE, J .
INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (02) :220-225
[3]  
GODWIN AK, 1994, AM J HUM GENET, V55, P666
[4]   A SOMATIC BRCA1 MUTATION IN AN OVARIAN TUMOR [J].
HOSKING, L ;
TROWSDALE, J ;
NICOLAI, H ;
SOLOMON, E ;
FOULKES, W ;
STAMP, G ;
SIGNER, E ;
JEFFREYS, A .
NATURE GENETICS, 1995, 9 (04) :343-344
[5]  
ICHIKAWA Y, 1994, CANCER RES, V54, P33
[6]  
JACOBS IJ, 1993, CANCER RES, V53, P1218
[7]  
JEN J, 1994, CANCER RES, V54, P5523
[8]   ALL IN THE (CANCER) FAMILY [J].
KNUDSON, AG .
NATURE GENETICS, 1993, 5 (02) :103-104
[9]   SOMATIC MUTATIONS IN THE BRCA1 GENE IN SPORADIC OVARIAN-TUMORS [J].
MERAJVER, SD ;
PHAM, TM ;
CADUFF, RF ;
CHEN, M ;
POY, EL ;
COONEY, KA ;
WEBER, BL ;
COLLINS, FS ;
JOHNSTON, C ;
FRANK, TS .
NATURE GENETICS, 1995, 9 (04) :439-443
[10]   A STRONG CANDIDATE FOR THE BREAST AND OVARIAN-CANCER SUSCEPTIBILITY GENE BRCA1 [J].
MIKI, Y ;
SWENSEN, J ;
SHATTUCKEIDENS, D ;
FUTREAL, PA ;
HARSHMAN, K ;
TAVTIGIAN, S ;
LIU, QY ;
COCHRAN, C ;
BENNETT, LM ;
DING, W ;
BELL, R ;
ROSENTHAL, J ;
HUSSEY, C ;
TRAN, T ;
MCCLURE, M ;
FRYE, C ;
HATTIER, T ;
PHELPS, R ;
HAUGENSTRANO, A ;
KATCHER, H ;
YAKUMO, K ;
GHOLAMI, Z ;
SHAFFER, D ;
STONE, S ;
BAYER, S ;
WRAY, C ;
BOGDEN, R ;
DAYANANTH, P ;
WARD, J ;
TONIN, P ;
NAROD, S ;
BRISTOW, PK ;
NORRIS, FH ;
HELVERING, L ;
MORRISON, P ;
ROSTECK, P ;
LAI, M ;
BARRETT, JC ;
LEWIS, C ;
NEUHAUSEN, S ;
CANNONALBRIGHT, L ;
GOLDGAR, D ;
WISEMAN, R ;
KAMB, A ;
SKOLNICK, MH .
SCIENCE, 1994, 266 (5182) :66-71